SCHEMBL30879080

SCHEMBL30879080

CC(C)[Si](C#Cc1cc(=O)n(-c2ccccc2)c2nc(Nc3ccc(C4CCNCC4)cc3)ncc12)(C(C)C)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.47
CAMK2D Q13557 1/20 0.46
JAK2 O60674 3/20 0.44
BRD4 O60885 3/20 0.44
JAK1 P23458 1/20 0.44
BRD2 P25440 1/20 0.44
JAK3 P52333 1/20 0.44
BRD3 Q15059 1/20 0.44
BRDT Q58F21 1/20 0.44
CSF1R P07333 2/20 0.42
CDK4 P11802 8/20 0.41
CDK6 Q00534 1/20 0.41
CCND1 P24385 7/20 0.41
CCND2 P30279 7/20 0.41
CCND3 P30281 7/20 0.41
NUAK1 O60285 1/20 0.41
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
FGFR3 P22607 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879031 0.91 WEE1 (0.48) JAK2BRD4JAK3CSF1RCDK4
SCHEMBL30878402 0.86 BTK (0.49) BTKCAMK2DJAK2BRD4JAK1
SCHEMBL30879036 0.85 WEE1 (0.47) BTKWEE1
SCHEMBL30878717 0.85 CDK4 (0.54) CDK4CDK6CCND1CCND2CCND3
SCHEMBL30879161 0.84 CCND3 (0.48) BTKJAK2BRD4JAK3CDK4
SCHEMBL30878824 0.83 CDK4 (0.45) CDK4CDK6CCND1CCND2CCND3
SCHEMBL30878988 0.82 CCND3 (0.51) BRD4CDK4CDK6CCND1CCND2
SCHEMBL30879056 0.82 CDK4 (0.47) BTKJAK2BRD4JAK1BRD2
SCHEMBL30878950 0.81 MAP4K1 (0.43) BTKCAMK2DJAK2JAK1JAK3
SCHEMBL30879189 0.81 CDK4 (0.52) JAK3CSF1RCDK4CDK6CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed